Pitavastatin calcium

CAS No. 147526-32-7

Pitavastatin calcium( Itabastatin | Itavastatin | NK 104 )

Catalog No. M12034 CAS No. 147526-32-7

Pitavastatin calcium is a novel member of the medication class of statins.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 51 In Stock
5MG 32 In Stock
10MG 51 In Stock
25MG 72 In Stock
50MG 91 In Stock
100MG 159 In Stock
200MG 222 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pitavastatin calcium
  • Note
    Research use only, not for human use.
  • Brief Description
    Pitavastatin calcium is a novel member of the medication class of statins.
  • Description
    Pitavastatin calcium is a novel member of the medication class of statins. The statins are a family of compounds that inhibit 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase, a pivotal enzyme in cholesterol biosynthesis. Pitavastatin is a potent inhibitor of HMG-CoA reductase (Ki = 1.7 nM). It lowers both total cholesterol and low density lipoprotein cholesterol in animals and humans. Metabolism of pitavastatin by the cytochrome P450 system is minimal, reducing the risk of drug-drug interactions. Moreover, pitavastatin causes atherosclerosis regression in humans with subclinical carotid atherosclerosis and improves cardiac function and survival in a rat model of hypertensive heart failure.(In Vitro):Pitavastatin Calcium inhibits the growth of a panel of ovarian cancer cells, including those considered most likely to represent HGSOC, grown as a monolayers (IC50 = 0.4-5 μM) or as spheroids (IC50=0.6-4 μM).Pitavastatin Calcium (1 μM; 48 hours ) induces apoptosis, evidenced by the increased activity of executioner caspases-3,7 as well as caspase-8 and caspase-9 in Ovcar-8 cells and Ovcar-3 cells.Pitavastatin (1 μM, 48 hours) causes PARP cleavage in Ovcar-8 cells.(In Vivo):Pitavastatin Calcium (59 mg/kg; p.o.; twice daily for 28 days) causes significant tumour regression.
  • In Vitro
    Western Blot Analysis Cell Line:Ovcar-8 cells Concentration:1?μM Incubation Time:48 hours Result:Induced PARP cleavage.
  • In Vivo
    Animal Model:4 week old female NCR Nu/Nu female mice?(bearing Ovcar-4 tumours)Dosage:59?mg/kg Administration:p.o.; twice daily for 28 days Result:Caused significant tumour regression.
  • Synonyms
    Itabastatin | Itavastatin | NK 104
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    cholesterol esters
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    147526-32-7
  • Formula Weight
    880.98
  • Molecular Formula
    C50H46CaF2N2O8
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 51 mg/mL (57.89 mM)
  • SMILES
    C1C(C1)C2=NC3=CC=CC=C3C(=C2/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C4=CC=C(C=C4)F.C1C(C1)C2=NC3=CC=CC=C3C(=C2/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C4=CC=C(C=C4)F.[Ca+2]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ahmad H, et al. Cardiol Rev, 2010, 18(5):264-267.
molnova catalog
related products
  • Taltirelin acetate

    Taltirelin acetate is a superagonist at thyrotropin-releasing hormone receptor (TRH-R)(IC50 of 910 nM and EC50 of 36 nM for stimulating an increase in cytosolic Ca2+ concentration (Ca2+ release)).

  • 2-Iodobenzoic acid

    2-Iodobenzoic acid is the impact-sensitive intermediate in the synthesis of the Dess-Martin periodinane.

  • Scutebarbatine A

    Scutebarbatine A shows significant antitumor effects on A549 cells in vivo and in vitro via mitochondria-mediated apoptosis by up-regulating expressions of caspase-3 and 9, and down-regulating Bcl-2.